Herbalife Nutrition Ltd (HOO.SG)
| Previous Close | 9.46 |
| Open | 10.27 |
| Bid | 10.31 x 50000 |
| Ask | 10.36 x 50000 |
| Day's Range | 10.27 - 10.27 |
| 52 Week Range | 7.00 - 16.99 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- StockStory
Personal Care Stocks Q1 Teardown: Coty (NYSE:COTY) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q1 now behind us, let’s have a look at Coty (NYSE:COTY) and its peers.
- Simply Wall St.
Herbalife (NYSE:HLF) stock falls 6.8% in past week as three-year earnings and shareholder returns continue downward trend
It's not possible to invest over long periods without making some bad investments. But really bad investments should be...
- Reuters
Nestle, Coke take cautious approach to catering to Ozempic users
NEW YORK (Reuters) -Nestle's new food brand for people taking weight-loss drugs like Wegovy will note that the meals are high in protein, fiber and nutrients, but will not name the blockbuster medications, a company executive told Reuters. The world's largest food maker is keeping the names of the drugs off the packaging due to regulatory concerns, Tom Moe, Nestle USA's president of meals, said in a recent interview. Nestle will instead market its Vital Pursuit line of $5-and-under frozen meals on social media, he said.
